Insider Transactions in Q2 2021 at Neuro Pace Inc (NPCE)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2021
|
Irina Ridley Chief Legal Officer/Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,681
+41.42%
|
-
|
|
Jun 04
2021
|
Rebecca Kuhn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,181
+41.77%
|
-
|
|
Jun 04
2021
|
Michael Favet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,590
+50.0%
|
-
|
|
Jun 04
2021
|
Martha Morrell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,181
+45.76%
|
-
|
|
Apr 26
2021
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Indirect |
334,027
+48.7%
|
-
|
|
Apr 26
2021
|
Michael Favet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
15,385
+40.14%
|
$0
$0.03 P/Share
|
|
Apr 26
2021
|
Michael Favet Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
7,562
+50.0%
|
-
|
|
Apr 26
2021
|
Greg Shaw Garfield Director |
BUY
Conversion of derivative security
|
Indirect |
5,614,384
+49.96%
|
-
|
|
Apr 26
2021
|
Accelmed Partners Ii L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,454,422
+46.08%
|
-
|
|
Apr 26
2021
|
Evan Norton Director |
BUY
Conversion of derivative security
|
Indirect |
3,454,422
+46.08%
|
-
|
|
Apr 26
2021
|
Frank M Fischer |
BUY
Conversion of derivative security
|
Direct |
472,366
+45.51%
|
-
|
|
Apr 26
2021
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,777,281
+48.49%
|
-
|
|
Apr 26
2021
|
Kck Ltd. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
5,595,493
+49.89%
|
-
|
|
Apr 21
2021
|
Evan Norton Director |
BUY
Open market or private purchase
|
Indirect |
588,235
+50.0%
|
$9,999,995
$17.0 P/Share
|
|
Apr 21
2021
|
Greg Shaw Garfield Director |
BUY
Open market or private purchase
|
Direct |
13,235
+25.41%
|
$224,995
$17.0 P/Share
|
|
Apr 21
2021
|
Frank M Fischer |
BUY
Open market or private purchase
|
Direct |
50,000
+34.89%
|
$850,000
$17.0 P/Share
|
|
Apr 21
2021
|
Accelmed Partners Ii L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
588,235
+50.0%
|
$9,999,995
$17.0 P/Share
|
|
Apr 21
2021
|
Irina Ridley Chief Legal Officer/Secretary |
BUY
Open market or private purchase
|
Direct |
2,352
+50.0%
|
$39,984
$17.0 P/Share
|
|
Apr 21
2021
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
235,000
+50.0%
|
$3,995,000
$17.0 P/Share
|